{"schema_version":"secwatch.filing_event.v1","accession":"0001773751-26-000161","form_type":"8-K","ticker":"HIMS","cik":"0001773751","company_name":"Hims & Hers Health, Inc.","filed_at":"2026-08-10T20:08:59+00:00","discovered_at":"2026-08-10T20:10:00.242601+00:00","generated_at":"2026-08-10T20:10:08.210935+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Hims & Hers Q2 revenue up 38% to $753M; raises FY26 guidance to $3.1-3.3B","bullets":["Q2 revenue $753.2M, +38% YoY; subscribers 2.89M, +19% YoY.","Net loss $86.3M vs income $42.5M; gross margin 64% vs 76%; Adjusted EBITDA $60.3M.","International revenue up 1,641% YoY to $131.4M, boosted by Eucalyptus acquisition.","Raises FY26 revenue guidance to $3.1-3.3B and Adjusted EBITDA to $275-325M.","Reaffirms 2030 targets of $6.5B revenue and $1.3B Adjusted EBITDA."],"urls":{"canonical":"https://secwatch.observer/filing/0001773751-26-000161","json":"https://secwatch.observer/filing/0001773751-26-000161.json","markdown":"https://secwatch.observer/filing/0001773751-26-000161.md","text":"https://secwatch.observer/filing/0001773751-26-000161.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1773751/000177375126000161/0001773751-26-000161-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1773751/000177375126000161/hims-20260810.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-10T20:10:08.210935+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}